Digestive Diamine Oxidase Enzyme For Supplements Market Worth $34.9 Million By 2030

Digestive Diamine Oxidase Enzyme For Supplements Market Growth & Trends

The global digestive diamine oxidase enzyme for supplements market size is expected to reach USD 34.9 million by 2030, expanding at 5.6% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Manufacturers are increasingly fortifying food and beverage products with enzymes, probiotics, and prebiotics. This is attributed to the consumer demand for food items with higher nutritional and fiber content. Digestive ingredients such as digestive diamine oxidase are widely used in supplements to avoid the risk of gastrointestinal diseases. This is expected to fuel the growth of the market over the forecast period.

The support of authoritative bodies such as the European Commission and the EPA toward the production and consumption of naturally-derived ingredients is likely to act in favor of the digestive diamine oxidase for the supplements industry. This scenario has pushed manufacturers to use naturally-derived ingredients.

In addition, supplement manufacturers are increasingly incorporating functional ingredients into products to increase their nutritional value. Ingredient suppliers and supplement manufacturers are focused on product innovation to expand their portfolio of probiotics and probiotic-based foods. This also aims to cater to the specific nutrition requirements of consumers with digestive health problems. The numerous new product launches are indicative of rising demand for digestive health food and beverages.

Increasing product awareness and robust branding by manufacturers are propelling the market growth. Rising incidences of chronic diseases and deficiencies are further augmenting the demand for functional foods. Digestive problems such as diarrhea, cramps, abdominal pain, bloating, and constipation occur due to a variety of reasons. In addition, certain conditions such as gastroesophageal reflux disease (GERD), diverticulitis, irritable bowel syndrome (IBS), and Crohn’s disease increase the risk of severe digestive issues. The demand for DAO enzymes has witnessed growth with a higher prevalence of digestive problems globally.

 Request a free sample copy or view report summary: Digestive Diamine Oxidase Enzyme For Supplements Market Report

Digestive Diamine Oxidase Enzyme For Supplements Market Report Highlights

• The ingredient segment is expected to expand at a significant CAGR of 5.64% from 2023 to 2030. The growth can be attributed to rising consumer demand for digestive health supplements

• Asia Pacific is estimated to grow significantly over the forecast period owing to the growing demand for healthy foods in the region

• The FDF level segment is growing at a robust CAGR of more than 5%, owing to favorable regulatory framework and supportive initiatives from governments globally

Digestive Diamine Oxidase Enzyme For Supplements Market Segmentation

Grand View Research has segmented the global digestive diamine oxidase enzyme for supplements market based on ingredient, Final Dosage Form (FDF), and region:

Digestive Diamine Oxidase Enzyme for Supplement Ingredient Outlook (Volume, Kilogram; Revenue, USD Million, 2017 - 2030)

Digestive Diamine Oxidase Enzyme for Supplement FDF Outlook (Volume, Kilogram; Revenue, USD Million, 2017 - 2030)

Digestive Diamine Oxidase Enzyme for Supplement Regional Outlook (Volume, Kilogram; Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

• Central & South America

  • Brazil

• Middle East & Africa

  • South Africa

List of Key Players in the Digestive Diamine Oxidase Enzyme for Supplements Market

• Seeking Health, LLC

• Eat All (Stada Group)

• Pure Encapsulations, LLC

• Enzymedica, Inc.

• Swanson

• XYMOGEN

• Klaire Labs